SCHEMBL18901736

SCHEMBL18901736

C=Cc1ccc(OC)cc1C=N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 11/20 0.46
CYP1A1 P04798 11/20 0.46
CYP1B1 Q16678 11/20 0.46
NFE2L2 Q16236 2/20 0.44
ALDH1A1 P00352 6/20 0.43
ERN1 O75460 1/20 0.42
TRIM24 O15164 1/20 0.42
TYR P14679 1/20 0.42
TRIM33 Q9UPN9 1/20 0.42
CYP3A4 P08684 3/20 0.41
TSHR P16473 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
KDM4E B2RXH2 3/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30567454 0.88 CYP1A2 (0.52) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL9065566 0.88 CYP1A2 (0.52) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL10861186 0.81 ALDH1A1 (0.61) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL3785302 0.80 CYP1A2 (0.70) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL629648 0.77 ALDH1A1 (0.61) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL1130309 0.76 CYP1A2 (0.48) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL4025438 0.76 ERN1 (0.44) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL1792533 0.76 CYP1A1 (0.61) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL11986284 0.76 ERN1 (0.44) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1
SCHEMBL30411244 0.76 CYP1A2 (0.70) CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2328865-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 EP disclosed